# Study of Safety and Efficacy of the Percutaneous Reduction of Mitral Valve Regurgitation in Heart Failure Patients

> **NCT00787293** · PHASE2 · SUSPENDED · sponsor: **Viacor** · enrollment: 30 (estimated)

## Conditions studied

- Heart Failure
- Mitral Regurgitation

## Interventions

- **DEVICE:** PTMA (Percutaneous Transvenous Mitral Annuloplasty) Implant

## Key facts

- **NCT ID:** NCT00787293
- **Lead sponsor:** Viacor
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** SUSPENDED
- **Start date:** 2008-10
- **Primary completion:** 2010-11
- **Final completion:** 2015-11
- **Target enrollment:** 30 (ESTIMATED)
- **Why stopped:** Company ended operations January 2011
- **Last updated:** 2011-02-14

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00787293

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00787293, "Study of Safety and Efficacy of the Percutaneous Reduction of Mitral Valve Regurgitation in Heart Failure Patients". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00787293. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*